PDTM-12. DLX2 TRANSCRIPTIONAL REGULATION OF CENTRAL NERVOUS SYSTEM CELL FATE RELEVANCE TO PEDIATRIC DIFFUSE MIDLINE GLIOMAS WITH HISTONE 3 MUTATIONS. (5th November 2018)
- Record Type:
- Journal Article
- Title:
- PDTM-12. DLX2 TRANSCRIPTIONAL REGULATION OF CENTRAL NERVOUS SYSTEM CELL FATE RELEVANCE TO PEDIATRIC DIFFUSE MIDLINE GLIOMAS WITH HISTONE 3 MUTATIONS. (5th November 2018)
- Main Title:
- PDTM-12. DLX2 TRANSCRIPTIONAL REGULATION OF CENTRAL NERVOUS SYSTEM CELL FATE RELEVANCE TO PEDIATRIC DIFFUSE MIDLINE GLIOMAS WITH HISTONE 3 MUTATIONS
- Authors:
- Nevin, Mikaela
Song, Xiaohua
Becher, Oren
Underhill, D Alan
Godbout, Roseline
Eisenstat, David - Abstract:
- Abstract: INTRODUCTION: Diffuse intrinsic pontine glioma (DIPG) is refractory to current therapy with less than 2% long term survivors. The identification of histone H3.1/H3.3 K27M mutations in most DIPG has provided new insights into the biology of this fatal disease. The DLX homeobox genes are expressed in the developing forebrain. The Dlx1/Dlx2 double knockout (DKO) mouse loses tangential GABAergic interneuron migration to the neocortex. We have identified genes that encode glutamic acid decarboxylase (GAD) enzymes as direct transcriptional targets of DLX1/DLX2. In DIPG patients with H3.3 K27M mutations there is decreased Dlx2 and increased expression of the myelin transcription factor, Myt1 . There is loss of H3 K27 tri-methylation (me 3 ) expression in many tumors with K27M mutations. METHODS AND RESULTS: We used bioinformatics approaches and chromatin immunoprecipitation (ChIP) assays to identify Olig2, Nkx2.2 and Myt1 promoter sequences as candidate DLX2 targets in vivo . DNA binding specificity was confirmed by gel shift assays in vitro . The functional consequences of Dlx2 co-expression with reporter constructs of ChIP-isolated promoter fragments of Olig2 and Nkx2.2 demonstrated repression of gene targets in vitro . qPCR showed increased Olig2 and Nkx2.2 expression in the DKO forebrain. Stable transfection of Dlx2 into a murine DIPG (mDIPG) cell line with the K27M mutation resulted in increased expression of Gad1 and Gad2 and decreased expression of Olig2 and Nkx2.2Abstract: INTRODUCTION: Diffuse intrinsic pontine glioma (DIPG) is refractory to current therapy with less than 2% long term survivors. The identification of histone H3.1/H3.3 K27M mutations in most DIPG has provided new insights into the biology of this fatal disease. The DLX homeobox genes are expressed in the developing forebrain. The Dlx1/Dlx2 double knockout (DKO) mouse loses tangential GABAergic interneuron migration to the neocortex. We have identified genes that encode glutamic acid decarboxylase (GAD) enzymes as direct transcriptional targets of DLX1/DLX2. In DIPG patients with H3.3 K27M mutations there is decreased Dlx2 and increased expression of the myelin transcription factor, Myt1 . There is loss of H3 K27 tri-methylation (me 3 ) expression in many tumors with K27M mutations. METHODS AND RESULTS: We used bioinformatics approaches and chromatin immunoprecipitation (ChIP) assays to identify Olig2, Nkx2.2 and Myt1 promoter sequences as candidate DLX2 targets in vivo . DNA binding specificity was confirmed by gel shift assays in vitro . The functional consequences of Dlx2 co-expression with reporter constructs of ChIP-isolated promoter fragments of Olig2 and Nkx2.2 demonstrated repression of gene targets in vitro . qPCR showed increased Olig2 and Nkx2.2 expression in the DKO forebrain. Stable transfection of Dlx2 into a murine DIPG (mDIPG) cell line with the K27M mutation resulted in increased expression of Gad1 and Gad2 and decreased expression of Olig2 and Nkx2.2 . Dlx2 stable transfection also resulted in decreased migration, invasion and colony number and size in vitro . Of significance, we demonstrated decreased expression of H3.3 K27M and restoration of H3.3 K27me 3 expression in Dlx2 stable transfected mDIPG cells. CONCLUSIONS: DLX transcription factors promote GABAergic interneuron and concomitant inhibition of oligodendroglial differentiation in neural progenitors by repression of a suite of genes including Olig2 and Nkx2.2 . Restoration of H3 K27me 3 expression in DIPG provides a promising lead towards exploration of differentiation as a therapeutic strategy for DIPG. … (more)
- Is Part Of:
- Neuro-oncology. Volume 20(2018)Supplement 6
- Journal:
- Neuro-oncology
- Issue:
- Volume 20(2018)Supplement 6
- Issue Display:
- Volume 20, Issue 6 (2018)
- Year:
- 2018
- Volume:
- 20
- Issue:
- 6
- Issue Sort Value:
- 2018-0020-0006-0000
- Page Start:
- vi206
- Page End:
- vi206
- Publication Date:
- 2018-11-05
- Subjects:
- Brain Neoplasms -- Periodicals
Brain -- Tumors -- Periodicals
Brain -- Cancer -- Periodicals
Nervous system -- Cancer -- Periodicals
616.99481 - Journal URLs:
- http://neuro-oncology.dukejournals.org/ ↗
http://neuro-oncology.oxfordjournals.org/ ↗
http://www.oxfordjournals.org/content?genre=journal&issn=1522-8517 ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/neuonc/noy148.854 ↗
- Languages:
- English
- ISSNs:
- 1522-8517
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6081.288000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12327.xml